Zim Laboratories Ltd. Statistics
Want to see IN:ZIMLAB full AI Analyst Report?
Zim Laboratories Ltd. (ZIMLAB) Stock Statistics & Valuation Metrics
Total Valuation
Zim Laboratories Ltd. has a market cap or net worth of INR 7.22B. The enterprise value is INR 8.69B.
- Market Cap
- INR 7.22B
- Enterprise Value
- INR 8.69B
Share Statistics
Zim Laboratories Ltd. has 53,658,490 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 53,658,490
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Zim Laboratories Ltd.’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 0.93%.
- Return on Equity (ROE)
- 0.02
- Return on Assets (ROA)
- 0.01
- Return on Invested Capital (ROIC)
- 0.93%
- Return on Capital Employed (ROCE)
- 0.02
- Revenue Per Employee
- 5.84M
- Profits Per Employee
- 92.38K
- Employee Count
- 632
- Asset Turnover
- 0.68
- Inventory Turnover
- 3.28
Valuation Ratios
The current PE Ratio of Zim Laboratories Ltd. is 266.08. Zim Laboratories Ltd.’s PEG ratio is -4.38.
- PE Ratio
- 266.08
- PS Ratio
- 1.83
- PB Ratio
- 2.59
- Price to FCF
- 186.70
- Price to Operating Cash Flow
- 37.99
- PEG Ratio
- -4.38
Income Statement
In the last 12 months, Zim Laboratories Ltd. had revenue of 3.69B and earned 58.38M in profits. Earnings per share was 1.19.
- Revenue
- 3.69B
- Gross Profit
- 616.36M
- Operating Income
- 56.68M
- Pretax Income
- 82.13M
- Net Income
- 58.38M
- EBITDA
- 256.46M
- Earnings Per Share (EPS)
- 1.19
Cash Flow
In the last 12 months, operating cash flow was 199.18M and capital expenditures -158.73M, giving a free cash flow of 40.45M billion.
- Operating Cash Flow
- 199.18M
- Free Cash Flow
- 40.45M
- Free Cash Flow per Share
- 0.75
Dividends & Yields
Zim Laboratories Ltd. pays an annual dividend of INR 0.17, resulting in a dividend yield of ―
- Dividend Per Share
- INR 0.17
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 0.27%
Stock Price Statistics
- Beta
- 0.82
- 52-Week Price Change
- 82.96%
- 50-Day Moving Average
- 136.46
- 200-Day Moving Average
- 105.57
- Relative Strength Index (RSI)
- 53.55
- Average Volume (3m)
- 10.55K
Important Dates
Zim Laboratories Ltd. upcoming earnings date is Feb 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 04, 2026
- Next Earnings Date
- Feb 01, 2027
- Ex-Dividend Date
- Sep 19, 2019
Financial Position
Zim Laboratories Ltd. as a current ratio of 1.45, with Debt / Equity ratio of 42.68%
- Current Ratio
- 1.45
- Quick Ratio
- 0.96
- Debt to Market Cap
- 0.42
- Net Debt to EBITDA
- 3.95
- Interest Coverage Ratio
- 0.44
Taxes
In the past 12 months, Zim Laboratories Ltd. has paid 23.75M in taxes.
- Income Tax
- 23.75M
- Effective Tax Rate
- 0.29
Enterprise Valuation
Zim Laboratories Ltd. EV to EBITDA ratio is 31.70, with an EV/FCF ratio of 0.00.
- EV to Sales
- 2.14
- EV to EBITDA
- 31.70
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Zim Laboratories Ltd. has INR 402.52M in cash and marketable securities with INR 0.00 in debt, giving a net cash position of INR 402.52M billion.
- Cash & Marketable Securities
- INR 402.52M
- Total Debt
- INR 0.00
- Net Cash
- INR 402.52M
- Net Cash Per Share
- INR 7.50
- Tangible Book Value Per Share
- INR 55.31
Margins
Gross margin is 33.06%, with operating margin of 1.41%, and net profit margin of 0.50%.
- Gross Margin
- 33.06%
- Operating Margin
- 1.41%
- Pretax Margin
- 0.65%
- Net Profit Margin
- 0.50%
- EBITDA Margin
- 6.74%
- EBIT Margin
- 1.41%
Analyst Forecast
The average price target for Zim Laboratories Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 13.14%
- EPS Growth Forecast
- -60.77%
Scores
- Smart Score
- ―
- AI Score
- 49.5
